About Sumida Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sumida Hospital
During the past decade, Sumida Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 4 clinical trials were completed, i.e. on
average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
2008-12-12
2017-07-27
Completed
2,825
A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)
2012-11-21
2015-03-25
Completed
551
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
2013-10-01
2016-10-01
Completed
271
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sumida Hospital" #1 sponsor was "Takeda" with 6 trials, followed by "Janssen Pharmaceutical K.K." with 5 trials
sponsored, "Pfizer" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "BioNTech SE"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sumida Hospital"
#1 collaborator was "Janssen Research & Development, LLC" with 3 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Sumida Hospital
According to Clinical.Site data, the most researched conditions in "Sumida Hospital" are
"Healthy" (4 trials), "Clinical Pharmacology" (2 trials), "Coronavirus Disease (COVID-19)" (2 trials), "COVID-19" (1 trials) and "Clostridium Difficile Associated Disease" (1 trials). Many other conditions were trialed in "Sumida Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Sumida Hospital
Most popular intervention types in "Sumida Hospital" are "Drug" (13 trials), "Biological" (7 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "TAK-925" (3 trials), "Rivaroxaban (BAY 59-7939, Xarelto) in ODT form" (2 trials), "Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form" (2 trials) and "TAK-019" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Sumida Hospital
The vast majority of trials in "Sumida Hospital" are
15 trials for "All" genders and 6 trials for "Male" genders.
Clinical Trials Status at Sumida Hospital
Currently, there are NaN active trials in "Sumida Hospital".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Sumida Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Sumida Hospital, 14 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".